Inhibition of Mycobacterium smegmatis using near-IR and blue light

J. Stephen Guffey, William C. Payne, Kyle A. Martin, Leslie N. James, Zhuoyuan Qian

Abstract


Background: Objective of current study is to determine whether near-IR, alone or combined with blue light and delivered at a low rate, could lower the dose needed to effectively inhibit Mycobacterium smegmatis in vitro. We have studied the effect of blue light on M. smegmatis and found that a bactericidal outcome can be obtained with high doses of blue light.

Methods: The organism was treated in vitro with 464, 850 and combined 464 & 850nm light emitted from a supraluminous diode (SLD) array. Doses of 30, 45 and 60 J/cm2 were used. Colony counts were performed and compared to untreated controls using Student t tests, a two-way Repeated Measures ANOVA and a one-way ANOVA with Tukey post hoc analysis.

Results: Statistically significant inhibition was observed for each individual wavelength and dose combination (p < 0.05). Two-way ANOVA demonstrated an interaction effect between wavelength and dose (F1, 9 = 358.585; p - 0.000). Post hoc analysis using one-way ANOVA (F2, 27 = 11.211; p = 0.00) and Tukey’s HSD identified 850nm at 45 J/cm2 to be the most effective wavelength / dose combination.

Conclusions: 850nm irradiation delivered at 45 J/cm2 is a wavelength /dose combination that can be expected to produce a significant inhibition of M. smegmatis in vitro.

 


Keywords


Near-IR, Mycobacterium, Bactericidal effect

Full Text:

PDF

References


Clardy J, Fischbach M, Currie C. The natural history of antibiotics. Curr BIol 2009;19(11):R437-41.

United States Department of Health and Human Services. Antibiotic Resistance Threats in the United States, 2013. Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/ drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf. Accessed 1 Nov 2013.

Dai T, Gupta A, Murray CK, Vrahas MS, Tegos GP, Hamblin MR. Blue light for infectious diseases: Propionibacterium acnes, Helicobacter pylori, and beyond? Drug Resist Updat 2012;15(4):223-36.

Nordmann P, Poirel L, Toleman MA, Walsh TR. Does broad-spectrum beta-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? J Antimicrob Che¬mother 2011;66(4):689-92.

Enwemeka CS. Antimicrobial Blue Light: An Emerging Alternative to Antibiotics. Photomed and Laser Surg 2013;31(11):509-11.

Dai T, Gupta A, Huang YY, Yin R, Murry CK, Vrehas MS, et al. Blue light rescues mice from potentially fatal Pseudomonas aeruginosa burn infection: efficacy, safety, and mechanism of action. Antimicrob Agents Chemother 2012;57:1238-45.

Guffey JS, Wilborn J. In vitro bactericidal effects of 405-nm and 470-nm blue light. Photomed Laser Surg 2006;24:684-8.

Guffey JS, Wilborn J. Effects of combined 405-nm and 880-nm light on Staphylococcus aureus and Pseudomonas aeruginosa in vitro. Photomed Laser Surg 2006;24:680-3.

Guffey J, Payne W, Jones T, Martin K. Evidence of resistance development by Staphylococcus aureus to an in vitro, multiple stage application of 405 nm light from a supraluminous diode array. Photomed Laser Surg 2013;31:179-82.

Guffey JS, Payne W, James L, Qian Z. Inactivation of Mycobacterium smegmatis following Exposure to 405-Nanometer Light from a Supraluminous Diode Array. WOUNDS 2013;25:131-5.

Guffey JS, Payne W, Qian Z, Martin K, James L, Dodson C. Enhancing the Effectiveness of Light as an Inhibitor of Candida albicans: Combination 624-nm and 850-nm Wavelengths Delivered at Low Rates. Int J Res Med Sci 2013;1(4):333-7.

Guffey JS, Payne W, James L, Qian Z, Dodson C. Inactivation of Candida albicans following Exposure to 624-Nanometer Light from a Supraluminous Diode Array. Manuscript in Review - Adv Skin Wound Care (in press).

Lee S, Seong I, Park K, Kim J, Cheon K, Kim S. Enhancement of cutaneous immune response to bacterial infection after low-level light therapy with 1072 nm infrared light: A preliminary study. J Photochem Photobiol 2011;105:175-82.

Dai T, Vrahas MS, Murray CK, Hamblin MR. Ultraviolet C irradiation: An alternative antimicrobial approach to localized infections? Expert Rev Anti Infect Ther 2012;10:185-95.

McDonald RS, Gupta S, Maclean M, Ramakrishnan P, Anderson JG, MacGregor SJ et al. 405nm light exposure of osteoblasts and inactivation of bacterial isolates from arthroplasty patients: Potential for new disinfection applications? Eur Cell Mater 2013;25:204-14.

Guffey JS, Payne W, Greenway J, Buchanan B, Dodson C, Lancaster K. Inhibition of Klebseilla Pneumoniae by Visible and Near-IR Radiation. Manuscript in Review.

Karu T. Primary and secondary mechanisms of action of visible to near-IR radiation on cells. J Photochem Photobiol B: Biol 1999;49:1-17.

Murdoch LE, Maclean M, Endarko E, MacGregor SJ, An¬derson JG. Bactericidal effects of 405 nm light exposure demonstrated by inactivation of Escherichia, Salmonella, Shigella, Listeria, and Mycobacterium species in liquid suspensions and on exposed surfaces. Scientific World ¬Journal. 2012;2012:137805.

Kiser K, Payne W, Taff T. Clinical Laboratory Microbiology: A Practical Approach. Chapter 26 Mycobacteria species. 1st ed. Upper Saddle River, New Jersey: Pearson Education, Inc.; 2011: 645-662.

Kiser K, Payne W, Taff T. Clinical Laboratory Microbiology: A Practical Approach. Chapter 4 The Host’s Encounter with Microbes. 1st ed. Upper Saddle River, New Jersey: Pearson Education, Inc.; 2011: 80-104.